Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Cell Reports Methods
|
September 16, 2025
Comparison of single-cell RNA-seq methods to enable transcriptome profiling of neutrophils in clinical samples
Klas Hatje, Kim Schneider, Sabrina Danilin, et al.
Life Science Alliance
|
May 17, 2022
DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF
Nuria Gutierrez-Prat, Hedwig L Zuberer, Luca Mangano, et al.
Journal of Visualized Experiments : Jove
|
May 4, 2026
Detecting Inter-Individual Contamination and Mismatches in Multiomics Next-Generation Sequencing Data
Zachary Whitfield, Przemyslaw Kiljan, Monika Krzyzanowska, et al.
BMC Cancer
|
March 19, 2025
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)
Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, et al.
Nature Methods
|
September 1, 2019
Assessment of network module identification across complex diseases
Sarvenaz Choobdar, Mehmet E Ahsen, Jake Crawford, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
Marina Natoli, Klas Hatje, Pratiksha Gulati, et al.
Nature Biotechnology
|
September 10, 2011
Verification of systems biology research in the age of collaborative competition
Pablo Meyer, Leonidas G Alexopoulos, Thomas Bonk, et al.
Cancer Immunology Research
|
November 16, 2021
BET Inhibition Enhances TNF-Mediated Antitumor Immunity
Lisa C Wellinger, Simon J Hogg, Dane M Newman, et al.
Nature Medicine
|
September 24, 2025
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial
Georgina V Long, Nitya Nair, Daniel Marbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2024
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Cell Reports Methods
|
September 16, 2025
Comparison of single-cell RNA-seq methods to enable transcriptome profiling of neutrophils in clinical samples
Klas Hatje, Kim Schneider, Sabrina Danilin, et al.
Life Science Alliance
|
May 17, 2022
DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF
Nuria Gutierrez-Prat, Hedwig L Zuberer, Luca Mangano, et al.
Journal of Visualized Experiments : Jove
|
May 4, 2026
Detecting Inter-Individual Contamination and Mismatches in Multiomics Next-Generation Sequencing Data
Zachary Whitfield, Przemyslaw Kiljan, Monika Krzyzanowska, et al.
BMC Cancer
|
March 19, 2025
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)
Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, et al.
Nature Methods
|
September 1, 2019
Assessment of network module identification across complex diseases
Sarvenaz Choobdar, Mehmet E Ahsen, Jake Crawford, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
Marina Natoli, Klas Hatje, Pratiksha Gulati, et al.
Nature Biotechnology
|
September 10, 2011
Verification of systems biology research in the age of collaborative competition
Pablo Meyer, Leonidas G Alexopoulos, Thomas Bonk, et al.
Cancer Immunology Research
|
November 16, 2021
BET Inhibition Enhances TNF-Mediated Antitumor Immunity
Lisa C Wellinger, Simon J Hogg, Dane M Newman, et al.
Nature Medicine
|
September 24, 2025
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial
Georgina V Long, Nitya Nair, Daniel Marbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2024
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, et al.
Page
of 4